Complementary and Alternative Medicine for Mood Disorders
The Carlat Psychiatry Report, Volume 10, Number 1, January 2012
Marlene Freeman, MD
Associate professor of psychiatry, Harvard Medical School, Director of clinical services, Perinatal and Reproductive Psychiatry Clinical Research Program, Massachusetts General Hospital
Dr. Freeman has received research support from Lilly, GlaxoSmithKline, and Forest Pharmaceuticals for the study of duloxetine, Lovaza (omega-3 fatty acid), and escitalopram. She has also served as a consultant to Bristol Myers Squibb on measurement based care. Dr. Carlat has reviewed this article and found no evidence of bias in this educational activity.
Defining CAM is challenging. One of the things that makes it so hard to have a concrete discussion on CAM is that it means different things to different people.